Navigation Links
AudioNotch Tinnitus Treatment Announces Holiday Sale
Date:12/13/2013

Toronto, Ontario (PRWEB) December 13, 2013

AudioNotch is the internet's leading proprietor of online tinnitus treatment. Offering Tailor-Made Notched Sound Therapy, AudioNotch provides an experimentally developed form of customized sound therapy for tinnitus sufferers worldwide.

Unlike many other tinnitus therapies available today, AudioNotch is designed to directly lower the volume of a patient's tinnitus tone. AudioNotch is also unique among sound therapies in that it does not require the usage of an expensive proprietary device, which inflates costs for patients. Instead, patients can use any MP3-capable playing device, such as an iPod, MP3 player, or smartphone. This allows AudioNotch to be financially accessible for a broad swath of patients.

For a limited time, AudioNotch is offering a significant discount to users worldwide - for the month of December 2013, AudioNotch subscriptions will be available for 50% off. This offer will end on January 1st, 2014. In order to claim the offer, click here.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11402212.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Tinnitus Treatment Summer Sale: AudioNotch Launches Reduced Prices Worldwide
2. AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing
3. Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting
4. Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
5. ALS Therapy Development Institute and Neurimmune Partner to Advance Treatments for ALS
6. Introducing a Personal Injury Chiropractor in Tampa Florida That is Utilizing the Latest Treatment Technology in the Industry, Courtesy of Elan Wellness Center
7. AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
8. IVF improving but fertility treatments keep multiple births high
9. UV-C Treatment—a New Procedure for Viral Inactivation, New and Upcoming Webinar Hosted by Xtalks
10. Anterios, Inc., Announces Results of Consumer Survey Revealing Widespread Problem of Excessive Sweating and Desire for New Topical Botulinum Toxin Treatment
11. Moving from Treatment to Management: MassDevice Focuses On Chronic Diseases and the Future Business Model of Med-tech at the 2013 Big 100 West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... OR (PRWEB) , ... January 18, 2017 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 ... Cyclone V E FPGA into a compact business-card sized form factor suitable for ...
(Date:1/18/2017)... Jan. 18, 2017 Applied BioMath ( ... to drug research and development, today announced that ... and CEO of Applied BioMath, will present at ... Modeling (BAGIM) Meeting on Thursday January 19, 2017 ... , MA.   Dr. Burke,s talk "Quantitative Modeling ...
(Date:1/18/2017)... ... January 18, 2017 , ... Total ... successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, ... The procedure was an anterior cervical discectomy and fusion on a 42 year ...
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, ... that it has submitted a 510(k) to the FDA, requesting clearance of the ... functional electrical stimulation (FES) technology. , The submission marks a major milestone ...
Breaking Biology Technology:
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
Breaking Biology News(10 mins):